The following documents help provide background on the work undertaken by the All Party Parliamentary Group for Child Health and Vaccine Preventable Diseases, the GAVI Alliance and PneumoADIP.
Message of Support from David Cameron MP
This written message of support has been given to the APPG in advance of activities for World Pneumonia Day by the Leader of the Conservative Party, the Rt Hon David Cameron MP
Message of Support from Nick Clegg MP
This written message of support has been given to the APPG in advance of activities for World Pneumonia Day by the Leader of the Liberal-Democrats, the Rt Hon Nick Clegg MP
Letter of Support from the Prime Minister, the Rt Hon Gordon Brown MP 13-10-2008
This letter of support to the APPG was recieved in advance of the launch of the Group’s report, Improving Child Health by Preventing Pneumococcal Disease.
Letter of Support from the Prime Minister, the Rt Hon Gordon Brown MP 19-12-2008
This letter from the Prime Minister, confirms the UK Government’s commitment to ending the enormous burden of preventable diseases such as pneumococcal disease and pneumonia through investments towards innovative financing mechanisms such as the AMC.
Improving Global Health by Preventing Pneumococcal Disease
This report, launched by the APPG on the 15th of October 2008, focuses on the global disease burden of pneumococcal disease and the potential impact of prevention through vaccination intiatives.
Improving Global Health by Preventing Pneumococcal Disease: Written and Oral Evidence
This document accompanies the APPG’s report: Improving Global Health by Preventing Pneumococcal Disease. It includes all of the oral and written evidence the APPG compiled prior to writing the report.
Advanced Market Commitment Launch
Five Nations and the Bill & Melinda Gates Foundation have Launched the Advance Market Commitment for Vaccines to Combat Pneumococcal Disease in Poor Nations US$1.5 billion pilot programme expected to save 5.4 million lives, protecting children from pneumonia and meningitis
Quick facts on pneumococcal disease and prevention by vaccination
What is PneumoADIP?
The PneumoADIP Mission PneumoADIP’s mission is to improve child survival and health by accelerating the evaluation of and access to, new life-saving pneumococcal vaccines for the world’s poorest children. PneumoADIP aims to achieve its mission by reducing and sharing risks with the private sector and in return obtaining a more sustainable, affordable supply of vaccine for developing countries. An effective and successful PneumoADIP could lead to millions of lives saved through earlier and faster access to vaccines.
GAVI Advanced Market Commitment Briefing Paper
Efforts to increase access to immunization have saved millions of lives in both industrialized and developing countries. However, in the world’s poorest countries gaps in coverage and vaccine availability remain. Sadly, every year, 3 million people die from diseases that could have been prevented by vaccines, 99% of whom live in the developing world.
Pneumonia and Pneumococcal Disease: Key Facts
This document lists the key facts surrounding pneumonia, pneumococcal and vaccines
HM Treasury information on the Advanced Market Commitment
The Advance Market Commitment (AMC) is an innovative, market-based mechanism with the potential to save millions of lives by accelerating access to vaccines in the world’s poorest countries, vaccines that would not otherwise be available for many years. The first AMC will target pneumococcal disease, bringing potentially life-saving vaccines more quickly to 100 million children and preventing over 5 million deaths by 2030.
Early Day Motion No 284: Pneumococcal Disease Prevention in the Developing World
Early Day Motion No 284: Pneumococcal Disease in the Developing World, was tabled on the 15th of November, 2007 by Chair of the All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World, Dr Desmond Turner MP.
For the full list of signatories go to:http://edmi.parliament.uk/EDMi/EDMDetails.aspx?EDMID=34395&SESSION;=891
APPG letter to the British Medical Journal
On the 22nd of January, the British Medical Journal (BMJ) published a letter to the editor from the Chair of the All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World, Dr Des Turner MP and fellow Group member, Dr Richard Taylor MP in response to an article concerning the treatment of severe pneumonia in children under five from the developing world.